Hatteras was founded in 2000 with the closing of Hatteras Venture Partners I, a seed-stage venture fund with $2.93 million in capital. Today, the firm is focused on seed- and early stage companies in ...

The NC Biopharma Networking Group will host a networking event on August 19. Whether you are new to networking or a seasoned veteran, this is a great opportunity to make valuable connections within ...

Bioventus, a Durham-based health care company, has received regulatory permission to begin marketing two medical devices that treat chronic pain. The U.S. Food and Drug Administration granted 510(k) ...

Precision BioSciences Inc., a clinical-stage company developing gene editing therapies for diseases with high unmet need, has ...

Final plans are taking shape for Wilson Community College’s Biomanufacturing Education and Skills Training (BEST) Center of Eastern North Carolina. The College recently revealed architectural ...

Coriolis Pharma, a German contract research, development and manufacturing organization, announced plans to invest $10.8 million and add 50 new jobs over the next five years in Morrisville. The ...

CytexOrtho, a Durham-based pre-clinical stage medical device company working to advance orthopaedic treatment options for cartilage repair, has won the inaugural OrthoPitch Technology Competition ...

The Triangle is known as a hotbed for innovation, thanks in large part to the partnerships between multiple stakeholders, including universities, investors and ecosystem support organizations. In that ...

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

On Friday, May 7, 2021, Alamance Community College will observe the groundbreaking of its groundbreaking $17.6 million Biotechnology Center of Excellence.

Scientist and entrepreneur Juliana Blum, Ph.D., has been named CEO of Durham-based BioAesthetics Corp., a biomaterials company that received early funding from the North Carolina Biotechnology ...